Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
What have you done to mitigate the pain
Published human trials report mild gastrointestinal discomfort in 814% of participants and transient headache in 57%, with symptoms typically resolving within 23 weeks
96160/96161 Risk assessment instruments
Transparency, Testing & Traceability Every batch of BPC-157 we supply is independently tested before it reaches a researchers laboratory
For broader tissue research, anti-aging biomarker research, or research questions requiring systemic distribution, injectable GHK-Cu dosage is more appropriate
However, direct studies on disc herniation models remain limited
US$ 20.92
US$ 21.67
US$ 28.13
US$ 27.10
